Stockscreener 앱 받기
10.22
11.82%
1.08
시간 외 거래:
10.40
0.18
+1.76%
전일 마감가:
$9.14
열려 있는:
$9.2
하루 거래량:
194.42K
Relative Volume:
1.00
시가총액:
$506.61M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.29%
1개월 성능:
+1.59%
6개월 성능:
+13.43%
1년 성능:
+0.00%
1일 변동 폭
$8.91
$10.25
1주일 범위
$8.91
$10.88
52주 변동 폭
$5.83
$26.25
Zenas Biopharma Inc Stock (ZBIO) Company Profile
명칭
Zenas Biopharma Inc
전화
857-271-2954
주소
852 WINTER STREET, SUITE 250, WALTHAM
ZBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBIO
Zenas Biopharma Inc
|
10.22 | 506.61M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-20 | 개시 | Wedbush | Outperform |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-12-16 | 개시 | H.C. Wainwright | Buy |
| 2024-11-05 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-08 | 개시 | Citigroup | Buy |
| 2024-10-08 | 개시 | Guggenheim | Buy |
| 2024-10-08 | 개시 | Jefferies | Buy |
| 2024-10-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Zenas Biopharma Inc 주식(ZBIO)의 최신 뉴스
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ZBIO LAWSUIT ALERT: Levi & Korsinsky Notifies Zenas - GlobeNewswire
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - Business Wire
Securities Fraud Class Action Filed Against Zenas BioPharma, Inc. (ZBIO)Levi & Korsinsky Reminds Investors of June 16, 2025 - ACCESS Newswire
ZBIO Investors Have Final Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
FINAL ALERT NOTICEZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsZBIO - marketscreener.com
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - The Malaysian Reserve
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
Join Class Action to Recover Losses from Zenas BioPharma, Inc. (ZBIO)Contact Levi & Korsinsky Before June 16, 2025 - ACCESS Newswire
Investor Alert: Deadline Approaching to Join Zenas BioPharma, Inc. (ZBIO) Class ActionContact Levi & Korsinsky - ACCESS Newswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - StreetInsider
Zenas BioPharma, Inc. Sued for Securities Law Violations – - GlobeNewswire
ZBIO Deadline: ZBIO Investors with Losses in Excess of $100K Have Opportunity to Lead Zenas BioPharma, Inc. Securities Lawsuit Filed by The Rosen Law Firm - GuruFocus
Zenas BioPharma, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & ... - Bluefield Daily Telegraph
ZBIO IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW - GlobeNewswire
ZBIO Investors Have the Opportunity to Lead the Zenas BioPharma Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - StreetInsider
Zenas BioPharma, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationZBIO - PR Newswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - GlobeNewswire Inc.
Zenas BioPharma Announces Board Changes at Annual Meeting - TipRanks
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors - GlobeNewswire
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025 – ZBIO - TradingView
The Gross Law Firm Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit ... - Bluefield Daily Telegraph
MONDAY INVESTOR DEADLINE: Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action LawsuitZBIO - GuruFocus
Investors who lost money on Zenas BioPharma, Inc.(ZBIO) should contact The Gross Law Firm about pending Class ActionZBIO - WV News
Zenas BioPharma, Inc. (ZBIO) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of June 16, 2025 Deadline - ACCESS Newswire
INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd Announces that Zenas BioPharma, Inc. (ZBIO) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire
Faruqi & Faruqi Reminds Zenas BioPharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025ZBIO - StreetInsider
ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, In - GuruFocus
ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsZBIO - Morningstar
Zenas BioPharma, Inc. Investors: Please contact the Portnoy - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma - The Malaysian Reserve
Zenas BioPharma, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; June 16, 2025 Deadline to file Lead Plaintiff Motion - TradingView
ZBIO DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Zenas BioPharma, Inc. Investors to ... - Eagle-Tribune
ZBIO DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Zenas BioPharma, Inc. Investors to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm – ZBIO - TradingView
Zenas BioPharma Class Action Lawsuit Filed by Levi & Korsinsky - Lawyer Monthly
Zenas BioPharma, Inc. Class Action: Levi & Korsinsky Reminds Zenas BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 16, 2025ZBIO - Kilgore News Herald
Shareholders of Zenas BioPharma, Inc. (ZBIO): Protect Your Rights Before June 16, 2025Contact Levi & Korsinsky - Stockhouse
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Investors in Zenas BioPharma, Inc. (ZBIO): Protect Your RightsContact Levi & Korsinsky Before June 16, 2025 - ACCESS Newswire
INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of - GlobeNewswire
Shareholders that lost money on Zenas BioPharma, Inc.(ZBIO) should contact The Gross Law Firm about pending Class ActionZBIO - WV News
ZBIO INVESTOR NOTICE: Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
ZBIO FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire
ZBIO FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. ... - Bluefield Daily Telegraph
ZBIO FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Zenas BioPharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm – ZBI - TradingView
2025-06-08 | Class Action Lawsuit Filed Against Zenas BioPharma, Inc. (ZBIO)Recover LossesContact Levi & Korsinsky Before June 16, 2025 | NDAQ:ZBIO | Press Release - Stockhouse
2025-06-08 | Lost Money on Zenas BioPharma, Inc. (ZBIO)? Urged to Join Class Action Before June 16, 2025Contact Levi & Korsinsky | NDAQ:ZBIO | Press Release - Stockhouse
ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Securities Class Action Lawsuit Filed Against Zenas BioPharma, Inc. (ZBIO)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Zenas Biopharma Inc (ZBIO) 재무 분석
Zenas Biopharma Inc (ZBIO)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Zenas Biopharma Inc 주식 (ZBIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Xiao Ting | Director |
Feb 07 '25 |
Buy |
7.76 |
10,000 |
77,600 |
47,000 |
| MOULDER LEON O JR | Chief Executive Officer |
Dec 04 '24 |
Buy |
9.98 |
45,000 |
449,100 |
241,155 |
| MOULDER LEON O JR | Chief Executive Officer |
Dec 03 '24 |
Buy |
10.76 |
25,000 |
269,000 |
196,155 |
| MOULDER LEON O JR | Chief Executive Officer |
Nov 18 '24 |
Buy |
15.00 |
7,500 |
112,500 |
168,655 |
| MOULDER LEON O JR | Chief Executive Officer |
Nov 19 '24 |
Buy |
14.57 |
2,500 |
36,425 |
171,155 |
| MOULDER LEON O JR | Chief Executive Officer |
Sep 18 '24 |
Buy |
17.91 |
10,000 |
179,100 |
1,662,039 |
| MOULDER LEON O JR | Chief Executive Officer |
Sep 20 '24 |
Buy |
18.45 |
5,000 |
92,270 |
1,672,039 |
| MOULDER LEON O JR | Chief Executive Officer |
Sep 19 '24 |
Buy |
17.89 |
5,000 |
89,450 |
1,667,039 |
| Enavate Sciences GP, LLC | 10% Owner |
Sep 16 '24 |
Buy |
17.00 |
882,353 |
15,000,001 |
3,761,359 |
| Lu Hongbo | Director |
Sep 13 '24 |
Buy |
17.00 |
58,823 |
999,991 |
58,823 |
1.45%
0.86%
자본화:
|
볼륨(24시간):